Oracle becoming stronger and stronger


Oracle Corporation (NASDAQ: ORCL) reported blow-out results once again. If you own Oracle, stay with it; if you do not own Oracle, I'd buy it.

We have been blogging for most of 2006 that Oracle's acquisition strategy is working and would be proven out by reporting great results -- which has come true. We first blogged about buying the stock at $14; it is now at $18, up close to 30%.

Ellison said during last night's conference call that Oracle is growing six times faster than SAP's new licenses. Ellison also began pounding the drum on how it is beating BEA in the middleware market.

Ellison's strategy of providing ERP, CRM and industry specific software is working big time.

Oracle is selling for 18x for FY2007 earnings and 15.4X FY2008 earnings, so Oracle is still a cheap stock. Stay with this stock, there is much more upside coming from earnings growth and potential for P/E expansion.
Symbol Lookup
IndexesChangePrice
DJIA-89.2312,801.23
NASDAQ-23.352,903.88
S&P 500-9.311,342.64

Last updated: February 13, 2012: 06:36 AM

Hot Stocks

General Electric

18.875-0.255(-1.33)

Alcoa

10.29-0.35(-3.29)

Apple Inc

493.42+0.25(+0.05)

Google Inc 'A'

605.91-5.55(-0.91)

Bank of America

8.07-0.11(-1.34)

Wal-Mart Stores

61.90-0.06(-0.10)

Exxon Mobil Corp

83.80-1.08(-1.27)

Ford

12.44-0.25(-1.97)

Citigroup

32.925-0.735(-2.18)

IBM

192.42-0.71(-0.37)

Yahoo

16.14+0.14(+0.88)

Starbucks

48.82-0.38(-0.77)

Microsoft

30.495-0.275(-0.89)

Home Depot

45.33+0.06(+0.13)

DailyFinance Headlines

Benzinga Headlines

TheFlyOnTheWall.com Headlines

BioHealth Investor Headlines

WalletPop Headlines

DailyFinance BlackBerry App

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

BioHealth Investor Headlines

Page Loaded in 1329132999374 ms.